Trials / Completed
CompletedNCT06624852
Clinical Validation of PROPECG-TMT
Clinical Validation of PROPECG-TMT: Evaluation of Ability of the Artificial Intelligence Model, PROPECG-TMT, to Improve Physician's in Screening Patients Who Needs Coronary Artery Revascularization Based on TMT-ECG.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This clinical validation evaluates the performances of physicians with and without learning with PROPECG-TMT assistance for screening coronary artery revascularization on TMT-ECG. There are two endpoints used to evaluate performances: Accuracy (primary endpoints with pair specificity/sensitivity, and PPV/NPV), and time needed for screening (secondary endpoints with time measurements in all cases).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Screening for coronary artery revascularization based on TMT-ECG | Screening for coronary artery revascularization based on TMT-ECG with and without the assistance of PROPECG-TMT |
Timeline
- Start date
- 2023-02-13
- Primary completion
- 2024-02-13
- Completion
- 2024-02-13
- First posted
- 2024-10-03
- Last updated
- 2024-10-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06624852. Inclusion in this directory is not an endorsement.